Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort
Overview
Authors
Affiliations
Background: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort.
Methods: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria. We included 8408 participants, aged 40-77. Participants with HF were divided into three categories according to their level of HF and evaluated for metabolic co-morbidities defined by the proposed criteria for MHF.
Results: HF was present in 13% (n = 1111) with a clear male preponderance (n = 771, 69% of HF). Within the HF group, 81% (n = 901) of subjects fulfilled the metabolic criteria and were defined as MHF, of which 75% (n = 674) were characterized by a major criterion. In the remaining HF cohort, 52% (n = 227 of 437) of subjects were classified as MHF after application of the minor criteria.
Conclusion: HF is a common finding in the general middle-aged population and the majority of cases are classified as MHF. The new classification provides useful criteria for defining MHF.
Anastasopoulos N, Barbouti A, Goussia A, Christodoulou D, Glantzounis G Cancers (Basel). 2025; 17(5).
PMID: 40075688 PMC: 11899477. DOI: 10.3390/cancers17050842.
Ausserwinkler M, Gensluckner S, Frey V, Gostner I, Paulweber B, Trinka E Rheumatol Int. 2025; 45(2):33.
PMID: 39825928 PMC: 11742769. DOI: 10.1007/s00296-024-05781-4.
Chang Y, Huang C, Kao J, Su T, Huang S, Tseng T Sci Rep. 2024; 14(1):19219.
PMID: 39160295 PMC: 11333767. DOI: 10.1038/s41598-024-70233-9.